Automated HPLC method and system for analyzing pegylated l-asparaginase drug activity

MYPI2024007229A0Pending Publication Date: 2026-06-13NATIONAL UNIVERSITY OF MALAYSIA
0 Cites 0 Cited by

Patent Information

Application Number
MYPI2024007229
Authority / Receiving Office
MY · MY
Patent Type
Applications
Current Assignee / Owner
Filing Date
2024-12-13
Publication Date
2026-06-13
Patent Text Reader

Abstract

The present invention provides a method and system for analyzing serum pegylated L-asparaginase activity levels. The invented method and system for analyzing serum pegylated L-asparaginase activity levels comprises an automated pre-column OPA-derivatization and injection protocol for the processed serum sample; an-optimized o-phthaldialdehyde (OPA) solution composition; an optimized HPLC condition; and an Excel macros. The automated pre-column OPA-derivatization and injection protocol enables automatic mixing and injection of the derivatized processed serum samples into the HPLC system for analysis. Further, the Excel macros enable automated computation using the linear assay calibration curve equations and automated unit conversions to calculate the serum pegylated L-asparaginase activity level. Fig 1.
Need to check novelty before this filing date? Find Prior Art